My guess is that a placement has been made to a group of unnamed sophisticates, but then again, big pharma might be keen to get in early and partner up with EMS before the conference. Very interesting that Patersons aren't managing the placement, given all the research etc they've done for EMS...
Quite a good presentation. EMS may appeal to a big pharma that wants to improve their public image. Fingers and toes crossed for a good announcement on Thursday! Good luck to all holders!
EMS Price at posting:
4.6¢ Sentiment: LT Buy Disclosure: Held
